PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Engineering, Yeditepe University, Istanbul, Turkey.\', \'Oral and Maxillofacial Surgery, Genome and Stem Cell Centre, Erciyes University, Kayseri, Turkey.\', \'Faculty of Medicine, Yeditepe University, Istanbul, Turkey.\', \'Faculty of Medicine, Erciyes University, Kayseri, Turkey.\', \'Vaccine Research and Development Application and Research Center, Erciyes University, Kayseri, Turkey.\', \'The Scientific and Technological Research Council of Turkey (TÜBITAK) Marmara Research Centre Energy Institute, Kocaeli, Turkey.\', \'Department of Molecular Biology and Genetics, Faculty of Science, Gebze Technical University, Kocaeli, Turkey.\', \'Department of Biology, Faculty of Science, Erciyes University, Kayseri, Turkey.\', \'Gevher Nesibe Genome and Stem Cell Institute, Erciyes University, Kayseri, Turkey.\', \'Antalya Training and Research Hospital, Antalya, Turkey.\', \'Department of Anesthesiology and Reanimation, School of Medicine, Marmara University, Istanbul, Turkey.\', \'Division of Rheumatology, Department of Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC, United States.\', \'Medical Biology, Department of Basic Medical Sciences, University of Health Sciences, Istanbul, Turkey.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2022.824378
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35401544
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all